HARRIGAN EDMUND
SEC CIK 1177917 · EDGAR
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
| 22 | HARRIGAN EDMUND | Dir | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:07 | 2026-06-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $113.36 | +255 | 23.0K | +1% | +$28.9K | |
| D | 2026-06-10 16:08 | 2026-06-08 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +1,642 | 22.8K | +8% | $0 |
| D | 2026-06-01 18:00 | 2026-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | HARRIGAN EDMUND | Dir | M - OptEx | — | +8,107 | 43.1K | +23% | — |
| 2026-04-02 16:10 | 2026-03-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $94.12 | +269 | 21.1K | +1% | +$25.3K | |
| 2026-01-05 | 2025-12-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $98.77 | +245 | 20.9K | +1% | +$24.2K | |
| 2025-10-02 | 2025-09-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $84.81 | +289 | 20.6K | +1% | +$24.5K | |
| 2025-07-02 | 2025-06-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $68.10 | +367 | 20.3K | +2% | +$25.0K | |
| D | 2025-06-12 | 2025-06-10 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +2,518 | 20.0K | +14% | $0 |
| D | 2025-06-02 | 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | HARRIGAN EDMUND | Dir | M - OptEx | — | +9,387 | 35.0K | +37% | — |
| 2025-04-02 | 2025-03-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $60.55 | +363 | 17.4K | +2% | +$22.0K | |
| 2025-01-03 | 2024-12-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $69.07 | +339 | 17.1K | +2% | +$23.4K | |
| 2024-10-02 | 2024-09-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $66.10 | +378 | 16.7K | +2% | +$25.0K | |
| 2024-07-02 | 2024-06-28 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $60.62 | +409 | 16.4K | +3% | +$24.8K | |
| D | 2024-06-14 | 2024-06-12 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +2,830 | 15.9K | +22% | $0 |
| D | 2024-05-31 | 2024-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | HARRIGAN EDMUND | Dir | M - OptEx | — | +6,652 | 25.7K | +35% | — |
| 2024-04-02 | 2024-03-28 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $56.97 | +413 | 13.1K | +3% | +$23.5K | |
| 2024-01-03 | 2023-12-29 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $62.79 | +423 | 12.7K | +3% | +$26.6K | |
| 2023-10-03 | 2023-09-29 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $57.77 | +389 | 12.3K | +3% | +$22.5K | |
| 2023-07-05 | 2023-06-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $62.25 | +390 | 11.9K | +3% | +$24.3K | |
| D | 2023-06-16 | 2023-06-14 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +2,505 | 11.5K | +28% | $0 |
| DM | 2023-06-05 | 2021-06-22+ | ACAD | ACADIA PHARMACEUTICALS INC | HARRIGAN EDMUND | Dir | M - OptEx | — | +18.0K | 19.0K | +1,800% | — |
| 2023-04-04 | 2023-03-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $72.27 | +326 | 8,995 | +4% | +$23.6K | |
| 2023-01-04 | 2022-12-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $80.32 | +302 | 8,669 | +4% | +$24.3K | |
| 2022-10-20 | 2022-10-19 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $69.59 | +165 | 8,367 | +2% | +$11.5K | |
| 2022-10-04 | 2022-09-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $66.64 | +250 | 8,202 | +3% | +$16.7K | |
| 2022-07-01 | 2022-06-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $75.97 | +236 | 7,952 | +3% | +$17.9K | |
| D | 2022-06-17 | 2022-06-15 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $0.00 | +2,144 | 7,716 | +38% | $0 |
| 2022-04-04 | 2022-03-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $79.42 | +240 | 5,572 | +5% | +$19.1K | |
| 2022-01-04 | 2021-12-31 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $73.40 | +253 | 5,332 | +5% | +$18.6K | |
| 2021-10-04 | 2021-09-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $68.78 | +237 | 5,079 | +5% | +$16.3K | |
| 2021-07-02 | 2021-06-30 | INCY | Incyte | HARRIGAN EDMUND | Dir | A - Grant | $84.13 | +208 | 4,842 | +4% | +$17.5K |
Purchase Sale Sale after option exercise All abbreviations